Interleukin-4 produces a breakdown of tolerance in vivo with autoantibody formation and tissue damage

Autoimmunity

Volumn 37, Issue 8, 2004, Pages 569-577

  Foote, Linda C ^a   Evans, John W ^a   Cifuni, Justin M ^a   Siracusa, Mark C ^a   Monteforte, Gina M ^a   McCole, Jennifer L ^a   D'Orazio, Christian C ^a   Hastings, William D ^b   Rothstein, Thomas L ^b  

^a MERRIMACK COLLEGE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Autoimmunity; B lymphocytes; Cytokines; Tolerance

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; INTERLEUKIN 4; LYSOZYME; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VIVO STUDY; KIDNEY DISEASE; LIVER INJURY; MALE; MICROSCOPY; MOUSE; NONHUMAN; PROTEINURIA; TISSUE INJURY; TRANSGENIC MOUSE;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD95; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; INTERLEUKIN-4; KIDNEY; MICE; MICE, TRANSGENIC; SELF TOLERANCE;

EID: 15044343705     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930400020602     Document Type: Article

References (57)

1. Nagata, S. and Golstein, P. (1995) "The Fas death factor", Science 267, 1449-1456.
2. Ashkenazi, A. and Dixit, V.M. (1998) "Death receptors: signaling and modulation", Science 281, 1305-1308.
3. Nagata, S (1999) "Fas ligand-induced apoptosis", Annu. Rev. Genet. 33, 29-55.
4. Schneider, P. and Tschopp, J. (2000) "Apoptosis induced by death receptors", Pharm. Acta. Helv. 74, 281-286.
5. Sartorius, U, Schmitz, I and Krammer, P.H. (2001) "Molecular mechanisms of death-receptor-mediated apoptosis", Chembiochem. 2, 20-29.
6. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. and Nagata, S. (1992) "Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis", Nature 356, 314-317.
7. Takahashi, T., Tanaka, M., Brannan, C.I., et al. (1994) "Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand", Cell 76, 969-976.
8. Nagata, S. and Suda, T. (1995) "Fas and Fas ligand: lpr and gld mutations", Immunol. Today 16, 39-43.
9. Fisher, G.H., Rosenberg, F.J., Straus, S.E., et al. (1995) "Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome", Cell 81, 935-946.
10. Rieux-Laucat, F., Le Deist, F., Hivroz, C., et al. (1995) "Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity", Science 268, 1347-1349.
11. Drappa, J., Vaishnaw, A.K., Sullivan, K.E., Chu, J.L. and Elkon, K.B. (1996) "Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity", N. Engl. J. Med. 335, 1643-1649.
12. Wu, J., Wilson, J., He, J., Xiang, L., Schur, P.H. and Mountz, J.D. (1996) "Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease", J. Clin. Investig. 98, 1107-1113.
13. Le Deist, F., Emile, J.F., Rieux-Laucat, F., et al. (1996) "Clinical, immunological, and pathological consequences of Fas-deficient conditions", Lancet 348, 719-723.
14. Nemazee, D., Guiet, C., Buerki, K. and Marshak-Rothstein, A. (1991) "B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras", J. Immunol. 147, 2536-2539.
15. Sobel, E.S., Kakkanaiah, V.N., Schiffenbauer, J., Reap, E.A., Cohen, P.L. and Eisenberg, R.A. (1998) "Novel immunoregulatory B cell pathways revealed by lpr- + mixed chimeras", J. Immunol. 160 1497-1503.
16. Fukuyama, H., Adachi, M., Suematsu, S., et al. (1998) "Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice", J. Immunol. 160, 3805-3811.
17. Rathmell, J.C., Cooke, M.P., He, W.Y., et al. (1995) "CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4 + T cells", Nature 376, 181-184.
18. Stalder, T., Hahn, S. and Erb, P. (1994) "Fas antigen is the major target molecule for CD4 + T cell-mediated cytotoxicity", J. Immunol. 152, 1127-1133.
19. Ju, S.T., Cui, H., Panka, D.J., Ettinger, R. and Marshak-Rothstein, A. (1994) "Participation of target Fas protein in apoptosis pathway induced by CD4 + Th1 and CD8 + cytotoxic T cells", Proc. Natl. Acad. Sci. USA 91, 4185-4189.
20. Daniel, P.T. and Krammer, P.H. (1994) "Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells", J. Immunol. 152, 5624-5632.
21. Watanabe, D., Suda, T. and Nagata, S. (1995) "Expression of Fas in B cells of the mouse germinal center and Fas- dependent killing of activated B cells", Int. Immunol. 7, 1949-1956.
22. Rothstein, T.L., Wang, J.K., Panka, D.J., Foote, L.C., Marshak-Rothstein, A., et al. (1995) "Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells", Nature 374, 163-165.
23. Schattner, E.J., Elkon, K.B., Yoo, D.H., et al. (1995) "CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway", J. Exp. Med. 182, 1557-1565.
24. Garrone, P., Neidhardt, E.M., Garcia, E., Galibert, L., van Kooten, C. and Banchereau, J (1995) "Fas ligation induces apoptosis of CD40-activated human B lymphocytes", J. Exp. Med. 182, 1265-1273.
25. Lagresle, C., Mondiere, P., Bella, C., Krammer, P.H. and Defrance, T. (1996) "Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis", J. Exp. Med. 183, 1377-1388.
26. Rathmell, J.C., Townsend, S.E., Xu, J.C., Flavell, R.A. and Goodnow, C.C. (1996) "Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor", Cell 87, 319-329.
27. Foote, L.C., Schneider, T.J., Fischer, G.M., et al. (1996) "Intracellular signaling for inducible antigen-receptor-mediated Fas resistance in B cells", J. Immunol. 157, 1878-1885.
28. Foote, L.C., Howard, R.G., Marshak-Rothstein, A. and Rothstein, T.L. (1996) "IL-4 induces Fas resistance in B cells", J. Immunol. 157, 2749-2753.
29. Foote, L.C., Marshak-Rothstein, A. and Rothstein, T.L. (1998) "Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded", J. Exp. Med. 187, 847-853.
30. Cooke, M.P., Heath, A.W., Shokat, K.M., et al. (1994) "Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells", J. Exp. Med. 179, 425-438.
31. Eris, J.M., Basten, A., Brink, R., Doherty, K., Kehry, M.R. and Hodgkin, P.D. (1994) "Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions", Proc. Natl. Acad. Sci. USA 91, 4392-4396.
32. Ho, W.Y., Cooke, M.P., Goodnow, C.C. and Davis, M.M. (1994) "Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4 + T cells", J. Exp. Med. 179, 1539-1549.
33. Erb, K.J., Ruger, B., von Brevern, M., Ryffel, B., Schimpl, A. and Rivett, K. (1997) "Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice", J. Exp. Med. 185, 329-339.
34. Goodnow, C.C. (1992) "Transgenic mice and analysis of B-cell tolerance", Annu. Rev. Immunol. 10, 489-518.
35. Goodnow, C.C., Crosbie, J., Adelstein, S., et al. (1988) "Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice", Nature 334, 676-682.
36. Tepper, R.I., Levinson, D.A., Stanger, B.Z., Campos-Torres, J., Abbas, A.K. and Leder, P. (1990) "IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice", Cell 62, 457-467.
37. Barth, R.F., Singla, O. and Ward, P.A. (1974) "Immunosuppressive effects of anti-lymphocyte serum in complement deficient mice. II. Evidence that activity is mediated by C3 independent antibodies", J. Immunol. 112, 858-861.
38. Damjanov, I. (2000) Pathology for Health-Related Professions (W.B. Saunders, Philadelphia).
39. Grennan, D.M., Moseley, A., Sloane, D., Pumphrey, R., Dick, W.C. and Buchanan, W.W. (1977) "The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus", Aust. N. Z. J. Med. 7, 625-629.
40. Weinstein, A., Bordwell, B., Stone, B., Tibbetts, C. and Rothfield, N.F. (1983) "Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus", Am. J. Med. 74, 206-216.
41. Wurster, A.L., Rodgers, V.L., White, M.F., Rothstein, T.L. and Grusby, M.J. (2002) "IL-4 mediated protection of primary B cells from apoptosis through STAT6-dependent upregulation of Bcl-xL", J. Biol. Chem. 277, 27169-27175.
42. Morris, S.C., Dragula, N.L. and Finkelman, F.D. (2002) "IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production", J. Immunol. 169, 1696-1704.
43. Burstein, H.J., Tepper, R.I., Leder, P. and Abbas, A.K. (1991) "Humoral immune functions in IL-4 transgenic mice", J. Immunol. 147, 2950-2956.
44. Mori, M., Morris, S.C., Orekhova, T., Marinaro, M., Giannini, E. and Finkelman, F.D. (2000) "IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival", J. Immunol. 164, 5704-5712.
45. Finkelman, F.D., Madden, K.B., Morris, S.C., et al. (1993) "Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes", J. Immunol. 151, 1235-1244.
46. Mackay, I.R. (2000) "Autoimmunity and primary biliary cirrhosis", Baillieres Best Pract. Res. Clin. Gastroenterol. 14 519-533.
47. Gershwin, M.E., Ansari, A.A., Mackay, I.R., et al. (2000) "Primary biliary cirrhosis: an orchestrated immune response against epithelial cells", Immunol. Rev. 174, 210-225.
48. Hershey, G.K., Friedrich, M.F., Esswein, L.A., Thomas, M.L. and Chatila, T.A. (1997) "The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor", N. Engl. J. Med. 337, 1720-1725.
49. Song, G.Y., Chung, C.S., Chaudry, I.H. and Ayala, A. (2000) "IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis", Surgery 128, 133-138.
50. Muret, J., Marie, C., Fitting, C., Payen, D. and Cavaillon, J.M. (2000) "Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures", Shock 13, 169-174.
51. Matsukawa, A., Kaplan, M.H., Hogaboam, C.M., Lukacs, N.W. and Kunkel, S.L. (2001) "Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis", J. Exp. Med. 193, 679-688.
52. DiPiro, J.T., Howdieshell, T.R., Goddard, J.K., Callaway, D.B., Hamilton, R.G. and Mansberger, A.R. Jr. (1995) "Association of interleukin-4 plasma levels with traumatic injury and clinical course", Arch. Surg. 130, 1159-1162, Discussion 1162-1163.
53. Torre, D., Tambini, R., Aristodemo, S., et al. (2000) "Anti-inflammatory response of IL-4, IL-10 and TGF-beta in patients with systemic inflammatory response syndrome", Mediators Inflamm. 9 193-195.
54. Desreumaux, P., Brandt, E., Gambiez, L., et al. (1997) "Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease", Gastroenterology 113, 118-126.
55. Berg, P.A., Klein, R. and Rocken, M. (1997) "Cytokines in primary biliary cirrhosis", Semin. Liver Dis. 17, 115-123.
56. Mizoguchi, A., Mizoguchi, E. and Bhan, A.K. (1999) "The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice", Gastroenterology 116, 320-326.
57. Rose, N.R. (2001) "Infection, mimics, and autoimmune disease", J. Clin. Investig. 107, 943-944.